Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
49,688,862
-
Share change
-
-1,223,415
-
Total reported value
-
$1,981,355,785
-
Put/Call ratio
-
188%
-
Price per share
-
$39.85
-
Number of holders
-
294
-
Value change
-
-$48,904,009
-
Number of buys
-
133
-
Number of sells
-
133
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q4 2017
As of 31 Dec 2017 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 294 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,688,862 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Vanguard Group Inc, Invesco Ltd., STATE STREET CORP, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, ACADIAN ASSET MANAGEMENT LLC, Champlain Investment Partners, LLC, and ROTHSCHILD ASSET MANAGEMENT INC.
This table shows 294 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.